Isolation and Characterization of a Bacteriocin with Anti-MRSA Activity from Bacillus sp. Strain WASM9-25M
Main Article Content
Abstract
The infection with methicillin resistant Staphylococcus aureus or MRSA has become a serious problem worldwide. The use of a bacteriocin as an alternative compound to overcome this problem is promising. The partially purified bacteriocin or PPB obtained from strain WASM9-25M showed anti-MRSA activity. The PPB was heat stable up to 100°C for 30 min and active within the pH range of 3-9. The inactivation after treatment with all proteolytic enzymes (trypsin, a-chymotrypsin and proteinase K) reveals its antimicrobial peptides. Therefore, this isolated strain WASM9-25M can be regarded as a bacteriocin producing bacteria. It was identified as Bacillus sp. by the 16S rRNA gene sequence. Tris-Tricine SDS-PAGE analysis revealed that bacteriocin from strain WASM9-25M had an apparent molecular weight of 3.14 kDa. PCR analysis showed the presence of iturin A, lichenysin synthetase C and bacillomycin D. The bioactive peptide from Bacillus sp. strain WASM9-25M has a potential for use as an alternative antibacterial agent for the treatment of infection with MRSA in the future.
Article Details
Section
Research Articles
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.